Fulvestrant (F)+Placebo vs F+Palbociclib First Line for Postmenopausal Hormone Receptor+ Advanced Breast Cancer

NCT02690480 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

189

Enrollment

OTHER

Sponsor class

Conditions

Breast Neoplasms

Interventions

DRUG: PD-0332991 (Palbociclib)
DRUG: Fulvestrant
DRUG: Placebo

Sponsor

Spanish Breast Cancer Research Group

Collaborators

[object Object]